Literature DB >> 6500680

Renal and systemic hemodynamics in sustained essential hypertension.

G M London, M E Safar, J E Sassard, J A Levenson, A C Simon.   

Abstract

Cardiac output (CO), renal blood flow (RBF), calf blood flow (CBF), and hepatic blood flow (HBF), glomerular filtration rate (GFR), and dopamine beta hydroxylase (D beta H) activity were studied in 198 men (67 normotensive controls and 131 hypertensive patients) of the same age with sustained uncomplicated essential hypertension. In the hypertensive men, the RBF and the RBF/CO ratio were significantly decreased (p less than 0.001). The RBF and RBF/CO ratio were negatively correlated with age (p less than 0.01), blood pressure (p less than 0.01), and D beta H activity (p less than 0.01). None of these relationships were observed with CBF and HBF. The observed decreases in RBF and the RBF/CO ratio in hypertensive men were reversed after administration of clonidine and alpha-methyldopa (p less than 0.01), but not after administration of propranolol. The study provides evidence that the reduction of renal perfusion in essential hypertension is partly reversible and related to an abnormality in the adrenergic system control.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6500680     DOI: 10.1161/01.hyp.6.5.743

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

Review 1.  Why beta-blockers are not cardioprotective in elderly patients with hypertension.

Authors:  Ehud Grossman; Franz H Messerli
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

Review 2.  Prostaglandins, the kidney, and hypertension.

Authors:  T W Wilson; R D Kaushal; M Dubois
Journal:  West J Med       Date:  1990-08

3.  One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study.

Authors:  Gaspare Parrinello; Salvatore Paterna; Daniele Torres; Pietro Di Pasquale; Manuela Mezzero; Gabriella La Rocca; Mauro Cardillo; Caterina Trapanese; Mario Caradonna; Giuseppe Licata
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 4.  Carvedilol and the kidney.

Authors:  A G Dupont
Journal:  Clin Investig       Date:  1992

5.  Acute and chronic effects of lisinopril on renal and systemic hemodynamics in hypertension.

Authors:  J P Degaute; M Leeman; C Reuse; E Carlier; A Schoutens; P Vandepapeliere
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

Review 6.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 7.  Do calcium channel blockers have renal protective effects?

Authors:  G P Reams
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

Review 8.  Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review.

Authors:  B Dahlöf
Journal:  Drugs       Date:  1988       Impact factor: 9.546

9.  Pre-treatment with the angiotensin receptor 1 blocker losartan protects renal blood flow and oxygen delivery after propofol-induced hypotension in pigs.

Authors:  Stephanie Franzén; Robert Frithiof
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.